4DMedical (Imbio)
Overview
4DMedical is a global medical technology company that provides advanced imaging software for respiratory diagnostics. Through its patented XV Technology®, 4DMedical enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sensitivity. In December 2023, 4DMedical acquired Imbio, a leader in artificial intelligence medical imaging solutions for chronic lung and cardiothoracic diseases. This acquisition expanded 4DMedical’s portfolio to include AI-driven diagnostic tools that provide comprehensive cardiothoracic analysis from standard CT scans.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Quantitative lung ventilation analysis (XV LVASu00ae, CT LVASu2122)
- Non-contrast ventilation-perfusion mapping (CT:VQu2122)
- Coronary Artery Calcification (CACu2122) quantification
- Early IPF Detection (IQ-UIPu2122)
- Functional Lung Density Analysis (LDAfu2122)
- Lung Density Analysis – Inspiration (LDAiu2122) for emphysema assessment
- Lung Texture Analysis (LTAu2122) for interstitial lung disease assessment
- Pulmonary Hypertension Assessment (PHAu2122)
- Automated airway measurement
- Cloud-based Software-as-a-Service (SaaS) delivery model
Use Cases
- Early detection and diagnosis of respiratory deficiencies
- Monitoring changes in lung function over time
- Assessment of emphysema and COPD
- Support for lung cancer screening programs
- Pulmonary embolism workups and CTEPH assessment
- Surgical planning and pulmonary vascular disease assessment
What Physicians Need to Know
For radiologists and cardiologists, 4DMedical (Imbio)'s CACu2122 tool can be invaluable for efficiently assessing coronary artery calcification from existing non-contrast chest CT scans, streamlining the evaluation of patients with dyspnea and aiding in distinguishing between cardiac and pulmonary causes. The automated RV/LV Analysisu2122 provides crucial quantitative data on right ventricular dilation, which can assist in risk stratification for pulmonary conditions like pulmonary embolism, potentially saving reporting time and standardizing reporting of right heart strain. These tools can provide objective, reproducible quantification and visualization, enhancing diagnostic accuracy and guiding referrals.
4DMedical (Imbio) solutions are designed for integration into clinical workflows. The CACu2122 software results are directly routed to PACS for immediate review and integration. Imbio's products, including Lung Density Analysis (LDA) and RV/LV Analysis, are available through global partners and can be integrated into radiology reporting workflows via platforms like the Nuance AI Marketplace and PowerShare Network. 4DMedical has also partnered with Blackford Analysis Inc. to distribute Imbio's medical imaging AI solutions through the Blackford Platformu2122, which is an AI marketplace that consolidates disparate AI clinical applications and provides access through integration, workflow, orchestration, and reporting. Imbio's Core Computing Platform (CCP) offers both cloud and on-premise hosted options for running computationally-intensive image algorithms, integrating with native DICOM tools and workflows.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Cloud (Imbio Cloud in AWS) or On-premise (Imbio Enterprise) |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Pulmonology, Radiology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate 4DMedical (Imbio)
Videos
Product demos, reviews, and walkthroughs for 4DMedical (Imbio).
4DMedical (ASX:4DX): Revolutionizing lung health through our patented XV Technologyu00ae
4DMedical





